Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Sharma, Satyavan
1987.
Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques.
p.
9.
Coles, Gerald C.
1989.
Comparative Biochemistry of Parasitic Helminths.
p.
125.
Coles, G.C.
1990.
Recent advances in laboratory models for evaluation of helminth chemotherapy.
British Veterinary Journal,
Vol. 146,
Issue. 2,
p.
113.
Iddon, Brian
1990.
Synthesis and Reactions of 2H‐Benzimidazole‐2‐Spirocyclohexanes: An Application of ”Umpolung“.
Bulletin des Sociétés Chimiques Belges,
Vol. 99,
Issue. 9,
p.
673.
McKellar, Quintin A.
and
Kinabo, Ludovick D.B.
1991.
The pharmacology of flukicidal drugs.
British Veterinary Journal,
Vol. 147,
Issue. 4,
p.
306.
Picot, S.
Querrec, M.
Ghez, J. L.
Goullier-Fleuret, A.
Grillot, R.
and
Ambroise-Thomas, P.
1992.
A new report of triclabendazole efficacy during invading phase fasciolasis.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 11,
Issue. 3,
p.
269.
STITT, A. W.
and
FAIRWEATHER, I.
1992.
Spermatogenesis inFasciola hepatica:an ultrastructural comparison of the effects of the anthelmintic, thiabendazole (“Fasinex”) and the microtubule inhibitor, tubulozole.
Invertebrate Reproduction & Development,
Vol. 22,
Issue. 1-3,
p.
139.
Stitt, A. W.
and
Fairweather, I.
1993.
Fasciola hepatica: Tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
Parasitology Research,
Vol. 79,
Issue. 7,
p.
529.
Stitt, A. W.
and
Fairweather, I.
1993.
Fasciola hepatica: the effect of the microtubule inhibitors colchicine and tubulozole-C on the ultrastructure of the adult fluke.
Parasitology,
Vol. 107,
Issue. 3,
p.
297.
Stitt, A. W.
and
Fairweather, I.
1994.
The effect of the sulphoxide metabolite of triclabendazole (‘Fasinex’) on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
Parasitology,
Vol. 108,
Issue. 5,
p.
555.
Arjona, Rafael
Riancho, José A.
Aguado, José M.
Salesa, Ricardo
and
González-Macías, JesÚs
1995.
Fascioliasis in Developed Countries: A Review of Classic and Aberrant Forms of the Disease.
Medicine,
Vol. 74,
Issue. 1,
p.
13.
Stitt, A.W.
Fairweather, I.
and
Mackender, R.O.
1995.
The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica.
International Journal for Parasitology,
Vol. 25,
Issue. 4,
p.
421.
Calvopiña, Manuel
Guderian, Ronald H.
Paredes, Wilson
Chico, Martha
and
Cooper, Philip J.
1998.
Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Vol. 92,
Issue. 5,
p.
566.
FAIRWEATHER, I.
and
BORAY, J.C.
1999.
Fasciolicides: Efficacy, Actions, Resistance and its Management.
The Veterinary Journal,
Vol. 158,
Issue. 2,
p.
81.
Walker, S. M.
McKinstry, B.
Boray, J. C.
Brennan, G. P.
Trudgett, A.
Hoey, E. M.
Fletcher, H.
and
Fairweather, I.
2004.
Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
Parasitology Research,
Vol. 94,
Issue. 6,
p.
427.
Mottier, L.
Virkel, G.
Solana, H.
Alvarez, L.
Salles, J.
and
Lanusse, C.
2004.
Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites intoFasciola hepatica.
Xenobiotica,
Vol. 34,
Issue. 11-12,
p.
1043.
Mottier, Lourdes
Moreno, Laura
Alvarez, Luis
Virkel, Guillermo
and
Lanusse, Carlos
2004.
Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation.
Journal of Pharmaceutical and Biomedical Analysis,
Vol. 35,
Issue. 5,
p.
991.
Keiser, Jennifer
Engels, Dirk
Büscher, Gottfried
and
Utzinger, Jürg
2005.
Triclabendazole for the treatment of fascioliasis and paragonimiasis.
Expert Opinion on Investigational Drugs,
Vol. 14,
Issue. 12,
p.
1513.
El Bialy, Serry A.
Taman, Amira
El-Beshbishi, Samar N.
Mansour, Basem
El-Malky, Mohamed
Bayoumi, Waleed A.
and
Essa, Hassan M.
2013.
Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection.
Parasitology Research,
Vol. 112,
Issue. 12,
p.
4221.
MEANEY, M.
SAVAGE, J.
BRENNAN, G. P.
HOEY, E.
TRUDGETT, A.
and
FAIRWEATHER, I.
2013.
Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
Parasitology,
Vol. 140,
Issue. 10,
p.
1287.